Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
7
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
new york blog main
biotech
deals
fda
new york top stories
san diego blog main
san diego top stories
drugs
new york
abbvie
alexion pharmaceuticals
boston
bristol-myers squibb
intercept pharmaceuticals
investing
nonalcoholic steatohepatitis
obeticholic acid
patisiran
pfizer
san francisco blog main
san francisco top stories
startups
4d molecular therapeutics
achaogen
acne
acorda therapeutics
adams street partners
agenus
akcea therapeutics
allergan
alnylam pharmaceuticals
ampyra
amyotrophic lateral sclerosis (als)
antibiotics
What
disease
7
×
drug
7
×
approved
medicines
fda
fatty
known
liver
nash
new
patients
pharma
pharmaceuticals
stop
treatment
year
acorda
ago
akcea
alnylam
alternative
amyloidosis
attr
autoimmune
available
bacteria
battle
bio
biopharma
business
candidate
caught
causing
companies
company
cope
data
deal
debilitating
dicerna
Language
unset
Current search:
disease
×
drug
×
" clinical trials "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections